622 related articles for article (PubMed ID: 34073952)
21. In silico evidence of direct interaction between statins and β-amyloid.
Shakour N; Bianconi V; Pirro M; Barreto GE; Hadizadeh F; Sahebkar A
J Cell Biochem; 2019 Mar; 120(3):4710-4715. PubMed ID: 30260016
[TBL] [Abstract][Full Text] [Related]
22. Simvastatin Sodium Salt and Fluvastatin Interact with Human Gap Junction Gamma-3 Protein.
Marsh A; Casey-Green K; Probert F; Withall D; Mitchell DA; Dilly SJ; James S; Dimitri W; Ladwa SR; Taylor PC; Singer DR
PLoS One; 2016; 11(2):e0148266. PubMed ID: 26863535
[TBL] [Abstract][Full Text] [Related]
23. Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update.
Schachter M
Fundam Clin Pharmacol; 2005 Feb; 19(1):117-25. PubMed ID: 15660968
[TBL] [Abstract][Full Text] [Related]
24. Explication of interactions between HMGCR isoform 2 and various statins through In silico modeling and docking.
Karthik MV; Satya Deepak MV; Shukla P
Comput Biol Med; 2012 Feb; 42(2):156-63. PubMed ID: 22177940
[TBL] [Abstract][Full Text] [Related]
25. Atorvastatin Exerts More Selective Inhibitory Effects on hMCT2 than on hMCT1 and hMCT4.
Yamaguchi A; Mukai Y; Sakuma T; Furugen A; Narumi K; Kobayashi M
Anticancer Res; 2023 Jul; 43(7):3015-3022. PubMed ID: 37351987
[TBL] [Abstract][Full Text] [Related]
26. Comparing the effects of five different statins on the HDL subpopulation profiles of coronary heart disease patients.
Asztalos BF; Horvath KV; McNamara JR; Roheim PS; Rubinstein JJ; Schaefer EJ
Atherosclerosis; 2002 Oct; 164(2):361-9. PubMed ID: 12204809
[TBL] [Abstract][Full Text] [Related]
27. Comparative Hepatic and Intestinal Metabolism and Pharmacodynamics of Statins.
Filppula AM; Hirvensalo P; Parviainen H; Ivaska VE; Lönnberg KI; Deng F; Viinamäki J; Kurkela M; Neuvonen M; Niemi M
Drug Metab Dispos; 2021 Aug; 49(8):658-667. PubMed ID: 34045219
[TBL] [Abstract][Full Text] [Related]
28. In silico interactions of statins with cell death-inducing DNA fragmentation factor-like effector A (CIDEA).
Barreto GE; Gonzalez J; Reiner Ž; Jamialahmadi T; Echeverria V; Ashraf GM; Sahebkar A
Chem Biol Interact; 2021 Aug; 345():109528. PubMed ID: 34022192
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.
Plans-Rubió P
Am J Cardiovasc Drugs; 2006; 6(3):177-88. PubMed ID: 16780391
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the anticancer effects of various statins on canine oral melanoma cells.
Ishikawa T; Irie N; Tashiro J; Osaki T; Warita T; Warita K; Naito M
Vet Comp Oncol; 2024 Mar; 22(1):156-161. PubMed ID: 38044042
[TBL] [Abstract][Full Text] [Related]
31. Systematic review with network meta-analysis: statins and risk of hepatocellular carcinoma.
Zhou YY; Zhu GQ; Wang Y; Zheng JN; Ruan LY; Cheng Z; Hu B; Fu SW; Zheng MH
Oncotarget; 2016 Apr; 7(16):21753-62. PubMed ID: 26943041
[TBL] [Abstract][Full Text] [Related]
32. Effects of acid and lactone forms of statins on S-warfarin 7-hydroxylation catalyzed by human liver microsomes and recombinant CYP2C9 variants (CYP2C9.1 and CYP2C9.3).
Shiozawa A; Yamaori S; Kamijo S; Ohmori S
Drug Metab Pharmacokinet; 2021 Feb; 36():100364. PubMed ID: 33341662
[TBL] [Abstract][Full Text] [Related]
33. More Western hypercholesterolemic patients achieve Japan Atherosclerosis Society LDL-C goals with rosuvastatin therapy than with atorvastatin, pravastatin, or simvastatin therapy.
Strutt K; Caplan R; Hutchison H; Dane A; Blasetto J
Circ J; 2004 Feb; 68(2):107-13. PubMed ID: 14745143
[TBL] [Abstract][Full Text] [Related]
34. Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta.
Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Kaitu'u-Lino TJ
BMC Pregnancy Childbirth; 2016 May; 16():117. PubMed ID: 27207105
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion.
Turner NA; Midgley L; O'Regan DJ; Porter KE
J Cardiovasc Pharmacol; 2007 Oct; 50(4):458-61. PubMed ID: 18049315
[TBL] [Abstract][Full Text] [Related]
36. Not all statins interfere with clopidogrel during antiplatelet therapy.
Mach F; Senouf D; Fontana P; Boehlen F; Reber G; Daali Y; de Moerloose P; Sigwart U
Eur J Clin Invest; 2005 Aug; 35(8):476-81. PubMed ID: 16101667
[TBL] [Abstract][Full Text] [Related]
37. Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care.
Harley CR; Gandhi SK; Heien H; McDonough K; Nelson SP
Expert Opin Pharmacother; 2008 Apr; 9(5):669-76. PubMed ID: 18345946
[TBL] [Abstract][Full Text] [Related]
38. Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells.
Sivaprasad U; Abbas T; Dutta A
Mol Cancer Ther; 2006 Sep; 5(9):2310-6. PubMed ID: 16985065
[TBL] [Abstract][Full Text] [Related]
39. Cholesterol-lowering drugs the simvastatin and atorvastatin change the protease activity of pepsin: An experimental and computational study.
Shahlaei M; Zamani P; Farhadian N; Balaei F; Ansari M; Moradi S
Int J Biol Macromol; 2021 Jan; 167():1414-1423. PubMed ID: 33202264
[TBL] [Abstract][Full Text] [Related]
40. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
